US FDA approves Korean regenerative wound dressing

Published: 2009-09-03 06:57:00

Updated: 2009-09-03 06:57:00

Sewon Cellontech said on August 31 that it has received approval from the U.S. Food and Drug Administration to market its TheraForm, an absorbable biomatrix membrane for wound dressing, in the US market.

The company said the approval comes after it submitted premarket notification for Therafor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK